Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Acute leukaemia, Acute lymphoblastic leukaemia (ALL), Blood cancers, Leukaemia
Closed
Phase 2
This trial is looking at a new combination of treatment for acute lymphoblastic leukaemia (ALL).
It is for people:
who have no signs of leukaemia in the blood or bone marrow (complete remission)
over the age of 40 and under 70
Recruitment start: 17 September 2018
Recruitment end: 30 September 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor David Marks
University of Birmingham
Anthony Nolan Research Institute
NHS Blood and Transplant (NHSBT)
Leuka
Last reviewed: 19 March 2024
CRUK internal database number: 15941